BioTrack Capital

BioTrack Capital

Shanghai, Shanghaibiotrackcapital.com

Overview

BioTrack Capital is a venture capital firm established in 2017 that focuses on investing in and incubating outstanding early-stage biotech, medtech as well as healthcare cross disciplinary sectors (AI and digital healthcare, consumer healthcare etc) . The firm manages four funds and has total assets under management over USD1Bn . Since its inception, BioTrack distinguishes itself as the entrepreneur founded VC with extensive industry ecosystem . Its ecosystem consists of leading global biopahrma, medtech companies and other multinational healthcare conglomerates, which not only provide deep industry insights and value-add service but also empower its portfolio companies in going overseas and global expansion .

Year Founded

2017

Portfolio Companies

27

Investments

CompanyDateStageLead
Aureka BiotechnologiesApr 2026Series A ExtensionCo-investor
Syneron BioMar 2026Series BCo-investor
Syneron BioMar 2026Series BCo-investor
PAQJan 2026Series B ExtensionCo-investor
Kyinno BioDec 2025Series BLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersShanghai, Shanghai
Year Founded2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.